SCHEMBL16637228

SCHEMBL16637228

CCOC(=O)/C(Cl)=N\Nc1ccc(OC)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
THRB P10828 1/20 0.43
KYAT1 Q16773 3/20 0.42
KCNQ3 O43525 1/20 0.42
KCNQ2 O43526 1/20 0.42
HTT P42858 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MITF O75030 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
ABCB1 P08183 1/20 0.40
GAA P10253 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PRKCZ Q05513 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16361973 1.00 MEN1 (0.45) MEN1KMT2ATHRBKYAT1KCNQ3
SCHEMBL16324087 1.00 MEN1 (0.45) MEN1KMT2ATHRBKYAT1KCNQ3
SCHEMBL19086432 0.90 KCNQ3 (0.48) MEN1KMT2AKYAT1KCNQ3KCNQ2
SCHEMBL17572304 0.90 KCNQ3 (0.48) MEN1KMT2AKYAT1KCNQ3KCNQ2
SCHEMBL19086431 0.90 KCNQ3 (0.48) MEN1KMT2AKYAT1KCNQ3KCNQ2
SCHEMBL21504268 0.86 MEN1 (0.38) MEN1KMT2AKCNQ3KCNQ2HTT
SCHEMBL19086454 0.86 ALDH1A1 (0.53) MEN1KMT2AKYAT1HTTKDM4E
SCHEMBL19086453 0.86 ALDH1A1 (0.53) MEN1KMT2AKYAT1HTTKDM4E
SCHEMBL17572363 0.86 ALDH1A1 (0.53) MEN1KMT2AKYAT1HTTKDM4E
SCHEMBL10410692 0.80 MAPT (0.59) MEN1KMT2ATHRBKYAT1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190111-B1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (CN) 2020-05-06 EP disclosed
US-9975893-B2 Pyrazolo[3,4-c]pyridine derivatives CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2018-05-22 US disclosed
CN-105324382-B Spirocyclic derivatives, its preparation method and the application of the ketone of 4,5 dihydro-pyrazolos [3,4 c] pyridine 2 四川海思科制药有限公司 2017-11-10 CN disclosed
US-20170291896-A1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2017-10-12 US disclosed
EP-3190111-A1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2017-07-12 EP disclosed
CN-105324382-A 4,5-dihydro-pyrazolo[3,4-c]pyridin-2-one spiro derivative, preparation method and use thereof SICHUAN HAISCO PHARMACEUTICAL CO LTD 2016-02-10 CN disclosed
WO-2015051713-A1 4,5-DIHYDRO-PYRAZOLO[3,4-C]PYRIDIN-2-ONE SPIRO DERIVATIVE, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2015-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170291896-A1 PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES F11, TFPI, F2 MEN1 1111/4885KMT2A 4066/4885THRB 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.